These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 8859286
21. Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation. Kim SB, Kim HM, Ahn H, Choi YJ, Hu KS, Oh W, Kim HJ. Toxins (Basel); 2021 Dec 25; 14(1):. PubMed ID: 35050994 [Abstract] [Full Text] [Related]
23. Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles. Sadick NS. Dermatol Surg; 2003 May 25; 29(5):501-7; discussion 507. PubMed ID: 12752518 [Abstract] [Full Text] [Related]
24. A four-month randomized, double-blind evaluation of the efficacy of botulinum toxin type A for the treatment of glabellar lines in women with skin types V and VI. Grimes PE, Shabazz D. Dermatol Surg; 2009 Mar 25; 35(3):429-35; discussion 435-6. PubMed ID: 19250310 [Abstract] [Full Text] [Related]
25. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety. Brandt F, Swanson N, Baumann L, Huber B. Dermatol Surg; 2009 Dec 25; 35(12):1893-901. PubMed ID: 19549186 [Abstract] [Full Text] [Related]
26. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. Ascher B, Zakine B, Kestemont P, Baspeyras M, Bougara A, Santini J. J Am Acad Dermatol; 2004 Aug 25; 51(2):223-33. PubMed ID: 15280841 [Abstract] [Full Text] [Related]
29. OnabotulinumtoxinA treatment of mild glabellar lines in repose. Carruthers A, Carruthers J, Lei X, Pogoda JM, Eadie N, Brin MF. Dermatol Surg; 2010 Dec 25; 36 Suppl 4():2168-71. PubMed ID: 21134048 [Abstract] [Full Text] [Related]
30. Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines. Carruthers A, Carruthers J, Flynn TC, Leong MS. Dermatol Surg; 2007 Jan 25; 33(1 Spec No.):S60-8. PubMed ID: 17241416 [Abstract] [Full Text] [Related]
31. Deep resting glabellar rhytides respond to BTX-A and Hylan B. Carruthers J, Carruthers A, Maberley D. Dermatol Surg; 2003 May 25; 29(5):539-44. PubMed ID: 12752525 [Abstract] [Full Text] [Related]
32. [Botulinum toxin for the treatment of major depressive disorder]. Hawlik AE, Freudenmann RW, Pinkhardt EH, Schönfeldt-Lecuona CJ, Gahr M. Fortschr Neurol Psychiatr; 2014 Feb 25; 82(2):93-9. PubMed ID: 24519192 [Abstract] [Full Text] [Related]
33. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study. Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Cranio; 2008 Apr 25; 26(2):126-35. PubMed ID: 18468272 [Abstract] [Full Text] [Related]
36. Botulinum toxin type A for the treatment of glabellar lines in Chinese: a double-blind, randomized, placebo-controlled study. Wu Y, Zhao G, Li H, Zheng Z, Zhong S, Yang Z, Feng Z, Yang Q, Zhu X. Dermatol Surg; 2010 Apr 25; 36(1):102-8. PubMed ID: 20002637 [Abstract] [Full Text] [Related]
38. Botulinum Toxin Type A Versus Placebo for Idiopathic Clubfoot: A Two-Center, Double-Blind, Randomized Controlled Trial. Alvarez CM, Wright JG, Chhina H, Howren A, Law P. J Bone Joint Surg Am; 2018 Sep 19; 100(18):1589-1596. PubMed ID: 30234623 [Abstract] [Full Text] [Related]
39. Botulinum A toxin for glabellar wrinkles. Dose and response. Hankins CL, Strimling R, Rogers GS. Dermatol Surg; 1998 Nov 19; 24(11):1181-3. PubMed ID: 9834736 [Abstract] [Full Text] [Related]